Skip to Content
Merck

Key Documents

View All Documentation

Skip To

09415

Sodium 4-aminosalicylate dihydrate

≥97.0% (T)

Synonym(s):

4-Amino-2-hydroxybenzoic acid sodium salt, 4-Amino-salicylic acid sodium salt

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
50 g
Please contact Customer Service for Availability
PLN 185.00

About This Item

Empirical Formula (Hill Notation):
C7H6NNaO3 · 2H2O
CAS Number:
6018-19-5
Molecular Weight:
211.15
NACRES:
NA.22
PubChem Substance ID:
329748763
UNSPSC Code:
41116107
EC Number:
205-091-2
MDL number:
MFCD00151044
Assay:
≥97.0% (T)
Form:
powder

PLN 185.00

Please contact Customer Service for Availability
​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Segment

200

assay

≥97.0% (T)

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

technique(s)

ligand binding assay: suitable

color

white to faintly beige

application(s)

peptide synthesis

SMILES string

O.O.[Na+].Nc1ccc(c(O)c1)C([O-])=O

InChI

1S/C7H7NO3.Na.2H2O/c8-4-1-2-5(7(10)11)6(9)3-4;;;/h1-3,9H,8H2,(H,10,11);;2*1H2/q;+1;;/p-1

InChI key

GMUQJDAYXZXBOT-UHFFFAOYSA-M

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
70862S2679H3766
Sodium 4-aminosalicylate dihydrate ≥97.0% (T)

Sigma-Aldrich

09415

Sodium 4-aminosalicylate dihydrate

4-Amino-1-naphthalenesulfonic acid sodium salt hydrate technical

Sigma-Aldrich

70862

4-Amino-1-naphthalenesulfonic acid sodium salt hydrate

Sodium salicylate 98.0-102.0% anhydrous basis, meets USP testing specifications

Sigma-Aldrich

S2679

Sodium salicylate

Sodium 4-hydroxybenzoate analytical standard

Supelco

H3766

Sodium 4-hydroxybenzoate

assay

≥97.0% (T)

assay

-

assay

98.0-102.0% anhydrous basis

assay

≥98.0% (HPLC)

reaction suitability

reaction type: solution phase peptide synthesis

reaction suitability

-

reaction suitability

-

reaction suitability

-

Quality Level

200

Quality Level

100

Quality Level

200

Quality Level

100

form

powder

form

crystals

form

crystalline

form

-

application(s)

peptide synthesis

application(s)

-

application(s)

pharmaceutical (small molecule)

application(s)

food and beverages

technique(s)

ligand binding assay: suitable

technique(s)

-

technique(s)

-

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0001257115

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

S M Vesenbeckh et al.
Infection, 40(2), 199-202 (2011-08-13)
para-Aminosalicylic acid (PAS) is commonly used in the treatment of drug-resistant tuberculosis, including multidrug-resistant tuberculosis. Since its first use in the 1940s, hypersensitivity reactions frequently limit its use in clinical practice. Cases of successful desensitization against PAS using orally administered
Shuichi Yano et al.
BMJ case reports, 2012, doi:10-doi:10 (2012-05-19)
Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent.
Lan Hong et al.
Drug metabolism and disposition: the biological fate of chemicals, 39(10), 1904-1909 (2011-07-20)
para-aminosalicylic acid (PAS; 4-amino-2-hydroxybenzoic acid), an antituberculosis drug in use since the 1950s, has recently been suggested to be an effective agent for treatment of manganese-induced parkinsonian disorders. However, the neuropharmacokinetics of PAS and its metabolite N-acetyl-para-aminosalicylic acid (AcPAS; N-acetyl-4-amino-2-hydroxybenzoic
View All Related Papers

Global Trade Item Number

SKUGTIN
278777-10G04061837836961
09415-50G04061838344724

Questions

Reviews

No rating value

Active Filters